Individual personality traits-particularly reward dependency-are actually linked to brain chemistry, researchers have confirmed by using positron emission tomography (PET).
Individual personality traits-particularly reward dependency-are actually linked to brain chemistry, researchers have confirmed by using positron emission tomography(PET).
This finding holds promise for better understanding and treating substance abuse and other addictive behaviours.The researchers focused their investigation for the first time on the role of the brain's opioidergic (or endorphine) system-specifically, the connection between an individual's level of reward expectancy and the brain's ability to transmit naturally occurring opiates.
The study was conducted on 23 males with no history of substance abuse, who were administered Fluoro-ethyl-diprenorphine-a radiolabeled chemical that binds readily to the brain's naturally occurring opiate system- and then underwent a PET scan.
They then compared the scans with the results of each participant's Cloninger temperament and character inventory, a questionnaire that assesses human personality based on four dimensions: novelty seeking, harm avoidance, reward dependence and persistence.
This revealed that the binding to opiate receptors in the ventral striatum-an area of the brain known to be a central part of the reward system-narrowly linked to the individual degree of reward dependence.
Those participants, who were seen to have a high need to feel rewarded by approval, were also those with the highest uptake of opiates, or endorphins, in the reward system.
Advertisement
He added: "This correlation means that people with high reward dependence have a high concentration of opiate receptors available in that area, while people with low dependence have fewer opiate receptors."
Advertisement
"This is a novel finding and will provide a deeper understanding of the functional relation between human personality, neurobiology and addictive behaviour," said Mathias Schreckenberger, M.D., professor of nuclear medicine, Johannes Gutenberg-University, Mainz, Germany.
The findings of the study are published in an article in The Journal of Nuclear Medicine.
Source-ANI
JAY/V